Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$8.54B |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$6.22B |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
+$6.12B |
| 4 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$5.39B |
| 5 |
Schwab 5-10 Year Corporate Bond ETF
SCHI
|
+$5.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Texas Instruments
TXN
|
+$367M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$335M |
| 3 |
Diageo
DEO
|
+$297M |
| 4 |
Medtronic
MDT
|
+$259M |
| 5 |
GE Aerospace
GE
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.36% |
| 2 | Financials | 10.66% |
| 3 | Healthcare | 9.68% |
| 4 | Consumer Discretionary | 8.35% |
| 5 | Industrials | 7.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Vanda Pharmaceuticals
VNDA
$307M
| $3.35M | ﹤0.01% |
592,737
-75,443
| -11% | -$390K |
|
2527
TETRA Technologies
TTI
$1.14B
| $3.35M | ﹤0.01% |
967,855
+25,139
| +3% | +$100K |
|
|
TELL
2528
DELISTED
Tellurian Inc.
TELL
| $3.3M | ﹤0.01% |
4,768,144
-551,645
| -10% | -$305K |
|
2529
Tejon Ranch
TRC
$457M
| $3.29M | ﹤0.01% |
192,984
+3,913
| +2% | +$65K |
|
2530
Adaptive Biotechnologies
ADPT
$3.59B
| $3.28M | ﹤0.01% |
906,481
+36,699
| +4% | +$116K |
|
2531
SandRidge Energy
SD
$514M
| $3.28M | ﹤0.01% |
253,533
+4,612
| +2% | +$63.9K |
|
|
BAND
2532
Bandwidth Inc
BAND
$1.26B
| $3.27M | ﹤0.01% |
193,572
+11,218
| +6% | +$212K |
|
|
HLVX
2533
DELISTED
HilleVax
HLVX
| $3.25M | ﹤0.01% |
224,867
+18,601
| +9% | +$256K |
|
2534
British American Tobacco
BTI
$131B
| $3.25M | ﹤0.01% |
105,008
+24,961
| +31% | +$758K |
|
2535
Janux Therapeutics
JANX
$925M
| $3.25M | ﹤0.01% |
77,516
+28,258
| +57% | +$1.33M |
|
|
EB
2536
DELISTED
Eventbrite
EB
| $3.21M | ﹤0.01% |
662,886
+5,374
| +0.8% | +$28K |
|
2537
Playtika
PLTK
$1.52B
| $3.2M | ﹤0.01% |
406,946
+9,230
| +2% | +$73.2K |
|
|
NFBK
2538
DELISTED
Northfield Bancorp
NFBK
| $3.18M | ﹤0.01% |
335,649
-2,379
| -0.7% | -$20.9K |
|
|
ITOS
2539
DELISTED
iTeos Therapeutics
ITOS
| $3.17M | ﹤0.01% |
213,738
+7,873
| +4% | +$113K |
|
2540
OraSure Technologies
OSUR
$279M
| $3.16M | ﹤0.01% |
742,639
-32,989
| -4% | -$168K |
|
2541
Ouster
OUST
$2.63B
| $3.16M | ﹤0.01% |
321,664
+127,645
| +66% | +$1.29M |
|
2542
Erasca
ERAS
$6.3B
| $3.15M | ﹤0.01% |
1,333,421
+669,551
| +101% | +$1.44M |
|
2543
Humacyte
HUMA
$176M
| $3.14M | ﹤0.01% |
654,372
+180,605
| +38% | +$940K |
|
|
SAVE
2544
DELISTED
Spirit Airlines, Inc.
SAVE
| $3.13M | ﹤0.01% |
856,488
+51,996
| +6% | +$201K |
|
2545
Banco Bilbao Vizcaya Argentaria
BBVA
$154B
| $3.13M | ﹤0.01% |
311,678
+36,641
| +13% | +$393K |
|
2546
SelectQuote
SLQT
$132M
| $3.11M | ﹤0.01% |
1,128,504
+44,674
| +4% | +$108K |
|
2547
Futu Holdings
FUTU
$14.7B
| $3.11M | ﹤0.01% |
47,448
+11,698
| +33% | +$791K |
|
2548
Vivid Seats
SEAT
$84.6M
| $3.11M | ﹤0.01% |
27,067
+1,397
| +5% | +$152K |
|
2549
Cardlytics
CDLX
$21.7M
| $3.11M | ﹤0.01% |
37,896
+6,184
| +20% | +$669K |
|
|
AVDL
2550
DELISTED
Avadel Pharmaceuticals
AVDL
| $3.1M | ﹤0.01% |
+220,701
| New | +$3.6M |
|
Similar funds
Charles Schwab's Q2 2024 Portfolio in Review
As of Q2 2024, Charles Schwab held 3,738 positions worth $525B, up 21% from $433B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Charles Schwab deployed $84.3B of net new capital in Q2 2024, opening 263 new positions and adding to 2,391 existing holdings. Its largest new stake was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Texas Instruments, an estimated $367M trimmed.
- Charles Schwab's largest Q2 2024 buy was Schwab Fundamental US Small Company Index ETF: 195,294,508 shares worth $5.36B.
- Charles Schwab added most to Schwab Fundamental US Large Company Index ETF in Q2 2024, an estimated $8.54B increase.
- Charles Schwab's biggest Q2 2024 reduction was Texas Instruments, cutting an estimated $367M.
- Charles Schwab fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $335M.
- Charles Schwab's ten largest holdings make up 21% of its $525B portfolio in Q2 2024.
- Charles Schwab opened 263 new positions and closed 116 in Q2 2024.
- Charles Schwab's portfolio value rose 21% quarter-over-quarter to $525B.
Based on Charles Schwab's 13F filing for Q2 2024, filed 12 Aug 2024.